Global Rare Disease Drug Market Research Report 2018
- QYR2798623
- 122 Pages
- October 2018
- Pharmaceuticals
This report studies the global Rare Disease Drug market status and forecast, categorizes the global Rare Disease Drug market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia).
The major manufacturers covered in this report
Novartis AG
Bristol-Myers Squibb Company
Celgene Corporation
F. Hoffmann-La Roche Ltd.
Pfizer, Inc.
Sanofi S.A.
Alexion Pharmaceuticals, Inc.
Eli Lilly and Company
Novo Nordisk A/S
AstraZeneca
Eisai Co., Ltd.
Daiichi Sankyo Company Limited
Bayer AG
GlaxoSmithKline
Merck & Co., Inc.
Johnson & Johnson
Biogen, Inc.
Shire
Amgen, Inc.
Deciphera
Atara Biotherapeutics
ProQR
Geographically, this report studies the top producers and consumers, focuses on product capacity, production, value, consumption, market share and growth opportunity in these key regions, covering
North America
Europe
China
Japan
Southeast Asia
India
We can also provide the customized separate regional or country-level reports, for the following regions:
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Rest of Asia-Pacific
Europe
Germany
France
UK
Italy
Spain
Russia
Rest of Europe
Central & South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Saudi Arabia
Turkey
Rest of Middle East & Africa
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
>1‰
0.65‰?1‰
<0.1‰
On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
Hospital Pharmacies
Speciality Pharmacies
Retail pharmacies
Others
The study objectives of this report are:
To analyze and study the global Rare Disease Drug capacity, production, value, consumption, status (2013-2017) and forecast (2018-2025);
Focuses on the key Rare Disease Drug manufacturers, to study the capacity, production, value, market share and development plans in future.
Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
To define, describe and forecast the market by type, application and region.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends and factors driving or inhibiting the market growth.
To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
To strategically profile the key players and comprehensively analyze their growth strategies.
In this study, the years considered to estimate the market size of Rare Disease Drug are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025
For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders
Rare Disease Drug Manufacturers
Rare Disease Drug Distributors/Traders/Wholesalers
Rare Disease Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations
With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:
Regional and country-level analysis of the Rare Disease Drug market, by end-use.
Detailed analysis and profiles of additional market players.
Global Rare Disease Drug Market Research Report 2018
1 Rare Disease Drug Market Overview
1.1 Product Overview and Scope of Rare Disease Drug
1.2 Rare Disease Drug Segment by Type (Product Category)
1.2.1 Global Rare Disease Drug Production and CAGR (%) Comparison by Type (Product Category)(2013-2025)
1.2.2 Global Rare Disease Drug Production Market Share by Type (Product Category) in 2017
1.2.3 >1‰
1.2.3 0.65‰?1‰
<0.1‰
1.3 Global Rare Disease Drug Segment by Application
1.3.1 Rare Disease Drug Consumption (Sales) Comparison by Application (2013-2025)
1.3.2 Hospital Pharmacies
1.3.3 Speciality Pharmacies
1.3.4 Retail pharmacies
1.3.5 Others
1.4 Global Rare Disease Drug Market by Region (2013-2025)
1.4.1 Global Rare Disease Drug Market Size (Value) and CAGR (%) Comparison by Region (2013-2025)
1.4.2 North America Status and Prospect (2013-2025)
1.4.3 Europe Status and Prospect (2013-2025)
1.4.4 China Status and Prospect (2013-2025)
1.4.5 Japan Status and Prospect (2013-2025)
1.4.6 Southeast Asia Status and Prospect (2013-2025)
1.4.7 India Status and Prospect (2013-2025)
1.5 Global Market Size (Value) of Rare Disease Drug (2013-2025)
1.5.1 Global Rare Disease Drug Revenue Status and Outlook (2013-2025)
1.5.2 Global Rare Disease Drug Capacity, Production Status and Outlook (2013-2025)
2 Global Rare Disease Drug Market Competition by Manufacturers
2.1 Global Rare Disease Drug Capacity, Production and Share by Manufacturers (2013-2018)
2.1.1 Global Rare Disease Drug Capacity and Share by Manufacturers (2013-2018)
2.1.2 Global Rare Disease Drug Production and Share by Manufacturers (2013-2018)
2.2 Global Rare Disease Drug Revenue and Share by Manufacturers (2013-2018)
2.3 Global Rare Disease Drug Average Price by Manufacturers (2013-2018)
2.4 Manufacturers Rare Disease Drug Manufacturing Base Distribution, Sales Area and Product Type
2.5 Rare Disease Drug Market Competitive Situation and Trends
2.5.1 Rare Disease Drug Market Concentration Rate
2.5.2 Rare Disease Drug Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Rare Disease Drug Capacity, Production, Revenue (Value) by Region (2013-2018)
3.1 Global Rare Disease Drug Capacity and Market Share by Region (2013-2018)
3.2 Global Rare Disease Drug Production and Market Share by Region (2013-2018)
3.3 Global Rare Disease Drug Revenue (Value) and Market Share by Region (2013-2018)
3.4 Global Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.5 North America Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.6 Europe Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.7 China Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.8 Japan Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.9 Southeast Asia Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
3.10 India Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
4 Global Rare Disease Drug Supply (Production), Consumption, Export, Import by Region (2013-2018)
4.1 Global Rare Disease Drug Consumption by Region (2013-2018)
4.2 North America Rare Disease Drug Production, Consumption, Export, Import (2013-2018)
4.3 Europe Rare Disease Drug Production, Consumption, Export, Import (2013-2018)
4.4 China Rare Disease Drug Production, Consumption, Export, Import (2013-2018)
4.5 Japan Rare Disease Drug Production, Consumption, Export, Import (2013-2018)
4.6 Southeast Asia Rare Disease Drug Production, Consumption, Export, Import (2013-2018)
4.7 India Rare Disease Drug Production, Consumption, Export, Import (2013-2018)
5 Global Rare Disease Drug Production, Revenue (Value), Price Trend by Type
5.1 Global Rare Disease Drug Production and Market Share by Type (2013-2018)
5.2 Global Rare Disease Drug Revenue and Market Share by Type (2013-2018)
5.3 Global Rare Disease Drug Price by Type (2013-2018)
5.4 Global Rare Disease Drug Production Growth by Type (2013-2018)
6 Global Rare Disease Drug Market Analysis by Application
6.1 Global Rare Disease Drug Consumption and Market Share by Application (2013-2018)
6.2 Global Rare Disease Drug Consumption Growth Rate by Application (2013-2018)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Rare Disease Drug Manufacturers Profiles/Analysis
7.1 Novartis AG
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Rare Disease Drug Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Novartis AG Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.1.4 Main Business/Business Overview
7.2 Bristol-Myers Squibb Company
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Rare Disease Drug Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Bristol-Myers Squibb Company Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.2.4 Main Business/Business Overview
7.3 Celgene Corporation
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Rare Disease Drug Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Celgene Corporation Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.3.4 Main Business/Business Overview
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Rare Disease Drug Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 F. Hoffmann-La Roche Ltd. Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.4.4 Main Business/Business Overview
7.5 Pfizer, Inc.
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Rare Disease Drug Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Pfizer, Inc. Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2015-2018)
7.5.4 Main Business/Business Overview
7.6 Sanofi S.A.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Rare Disease Drug Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Sanofi S.A. Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.6.4 Main Business/Business Overview
7.7 Alexion Pharmaceuticals, Inc.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Rare Disease Drug Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Alexion Pharmaceuticals, Inc. Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.7.4 Main Business/Business Overview
7.8 Eli Lilly and Company
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Rare Disease Drug Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Eli Lilly and Company Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.8.4 Main Business/Business Overview
7.9 Novo Nordisk A/S
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Rare Disease Drug Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Novo Nordisk A/S Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.9.4 Main Business/Business Overview
7.8 AstraZeneca
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Rare Disease Drug Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 AstraZeneca Rare Disease Drug Capacity, Production, Revenue, Price and Gross Margin (2013-2018)
7.10.4 Main Business/Business Overview
7.11 Eisai Co., Ltd.
7.12 Daiichi Sankyo Company Limited
7.13 Bayer AG
7.14 GlaxoSmithKline
7.15 Merck & Co., Inc.
7.16 Johnson & Johnson
7.17 Biogen, Inc.
7.18 Shire
7.19 Amgen, Inc.
7.20 Deciphera
7.21 Atara Biotherapeutics
7.22 ProQR
8 Rare Disease Drug Manufacturing Cost Analysis
8.1 Rare Disease Drug Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Rare Disease Drug
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Rare Disease Drug Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Rare Disease Drug Major Manufacturers in 2017
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Rare Disease Drug Market Forecast (2018-2025)
12.1 Global Rare Disease Drug Capacity, Production, Revenue Forecast (2018-2025)
12.1.1 Global Rare Disease Drug Capacity, Production and Growth Rate Forecast (2018-2025)
12.1.2 Global Rare Disease Drug Revenue and Growth Rate Forecast (2018-2025)
12.1.3 Global Rare Disease Drug Price and Trend Forecast (2018-2025)
12.2 Global Rare Disease Drug Production, Consumption , Import and Export Forecast by Region (2018-2025)
12.2.1 North America Rare Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.2 Europe Rare Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.3 China Rare Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.4 Japan Rare Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.5 Southeast Asia Rare Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.2.6 India Rare Disease Drug Production, Revenue, Consumption, Export and Import Forecast (2018-2025)
12.3 Global Rare Disease Drug Production, Revenue and Price Forecast by Type (2018-2025)
12.4 Global Rare Disease Drug Consumption Forecast by Application (2018-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
Figure Picture of Rare Disease Drug
Figure Global Rare Disease Drug Production (K Doses) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Rare Disease Drug Production Market Share by Types (Product Category) in 2017
Figure Product Picture of >1‰
Table Major Manufacturers of >1‰
Figure Product Picture of 0.65‰?1‰
Table Major Manufacturers of 0.65‰?1‰
Figure Product Picture of <0.1‰
Table Major Manufacturers of <0.1‰
Figure Global Rare Disease Drug Consumption (K Doses) by Applications (2013-2025)
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Speciality Pharmacies Examples
Table Key Downstream Customer in Speciality Pharmacies
Figure Retail pharmacies Examples
Table Key Downstream Customer in Retail pharmacies
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Rare Disease Drug Market Size (Million USD), Comparison (K Doses) and CAGR (%) by Regions (2013-2025)
Figure North America Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Rare Disease Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Rare Disease Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Global Rare Disease Drug Capacity, Production (K Doses) Status and Outlook (2013-2025)
Figure Global Rare Disease Drug Major Players Product Capacity (K Doses) (2013-2018)
Table Global Rare Disease Drug Capacity (K Doses) of Key Manufacturers (2013-2018)
Table Global Rare Disease Drug Capacity Market Share of Key Manufacturers (2013-2018)
Figure Global Rare Disease Drug Capacity (K Doses) of Key Manufacturers in 2017
Figure Global Rare Disease Drug Capacity (K Doses) of Key Manufacturers in 2018
Figure Global Rare Disease Drug Major Players Product Production (K Doses) (2013-2018)
Table Global Rare Disease Drug Production (K Doses) of Key Manufacturers (2013-2018)
Table Global Rare Disease Drug Production Share by Manufacturers (2013-2018)
Figure 2017 Rare Disease Drug Production Share by Manufacturers
Figure 2017 Rare Disease Drug Production Share by Manufacturers
Figure Global Rare Disease Drug Major Players Product Revenue (Million USD) (2013-2018)
Table Global Rare Disease Drug Revenue (Million USD) by Manufacturers (2013-2018)
Table Global Rare Disease Drug Revenue Share by Manufacturers (2013-2018)
Table 2017 Global Rare Disease Drug Revenue Share by Manufacturers
Table 2018 Global Rare Disease Drug Revenue Share by Manufacturers
Table Global Market Rare Disease Drug Average Price (USD/Dose) of Key Manufacturers (2013-2018)
Figure Global Market Rare Disease Drug Average Price (USD/Dose) of Key Manufacturers in 2017
Table Manufacturers Rare Disease Drug Manufacturing Base Distribution and Sales Area
Table Manufacturers Rare Disease Drug Product Category
Figure Rare Disease Drug Market Share of Top 3 Manufacturers
Figure Rare Disease Drug Market Share of Top 5 Manufacturers
Table Global Rare Disease Drug Capacity (K Doses) by Region (2013-2018)
Figure Global Rare Disease Drug Capacity Market Share by Region (2013-2018)
Figure Global Rare Disease Drug Capacity Market Share by Region (2013-2018)
Figure 2017 Global Rare Disease Drug Capacity Market Share by Region
Table Global Rare Disease Drug Production by Region (2013-2018)
Figure Global Rare Disease Drug Production (K Doses) by Region (2013-2018)
Figure Global Rare Disease Drug Production Market Share by Region (2013-2018)
Figure 2017 Global Rare Disease Drug Production Market Share by Region
Table Global Rare Disease Drug Revenue (Million USD) by Region (2013-2018)
Table Global Rare Disease Drug Revenue Market Share by Region (2013-2018)
Figure Global Rare Disease Drug Revenue Market Share by Region (2013-2018)
Table 2017 Global Rare Disease Drug Revenue Market Share by Region
Figure Global Rare Disease Drug Capacity, Production (K Doses) and Growth Rate (2013-2018)
Table Global Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table North America Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Europe Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table China Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Japan Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Southeast Asia Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table India Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Table Global Rare Disease Drug Consumption (K Doses) Market by Region (2013-2018)
Table Global Rare Disease Drug Consumption Market Share by Region (2013-2018)
Figure Global Rare Disease Drug Consumption Market Share by Region (2013-2018)
Figure 2017 Global Rare Disease Drug Consumption (K Doses) Market Share by Region
Table North America Rare Disease Drug Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Europe Rare Disease Drug Production, Consumption, Import & Export (K Doses) (2013-2018)
Table China Rare Disease Drug Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Japan Rare Disease Drug Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Southeast Asia Rare Disease Drug Production, Consumption, Import & Export (K Doses) (2013-2018)
Table India Rare Disease Drug Production, Consumption, Import & Export (K Doses) (2013-2018)
Table Global Rare Disease Drug Production (K Doses) by Type (2013-2018)
Table Global Rare Disease Drug Production Share by Type (2013-2018)
Figure Production Market Share of Rare Disease Drug by Type (2013-2018)
Figure 2017 Production Market Share of Rare Disease Drug by Type
Table Global Rare Disease Drug Revenue (Million USD) by Type (2013-2018)
Table Global Rare Disease Drug Revenue Share by Type (2013-2018)
Figure Production Revenue Share of Rare Disease Drug by Type (2013-2018)
Figure 2017 Revenue Market Share of Rare Disease Drug by Type
Table Global Rare Disease Drug Price (USD/Dose) by Type (2013-2018)
Figure Global Rare Disease Drug Production Growth by Type (2013-2018)
Table Global Rare Disease Drug Consumption (K Doses) by Application (2013-2018)
Table Global Rare Disease Drug Consumption Market Share by Application (2013-2018)
Figure Global Rare Disease Drug Consumption Market Share by Applications (2013-2018)
Figure Global Rare Disease Drug Consumption Market Share by Application in 2017
Table Global Rare Disease Drug Consumption Growth Rate by Application (2013-2018)
Figure Global Rare Disease Drug Consumption Growth Rate by Application (2013-2018)
Table Novartis AG Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis AG Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novartis AG Rare Disease Drug Production Growth Rate (2013-2018)
Figure Novartis AG Rare Disease Drug Production Market Share (2013-2018)
Figure Novartis AG Rare Disease Drug Revenue Market Share (2013-2018)
Table Bristol-Myers Squibb Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bristol-Myers Squibb Company Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Production Growth Rate (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Production Market Share (2013-2018)
Figure Bristol-Myers Squibb Company Rare Disease Drug Revenue Market Share (2013-2018)
Table Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Corporation Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Celgene Corporation Rare Disease Drug Production Growth Rate (2013-2018)
Figure Celgene Corporation Rare Disease Drug Production Market Share (2013-2018)
Figure Celgene Corporation Rare Disease Drug Revenue Market Share (2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Ltd. Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Production Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Production Market Share (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Rare Disease Drug Revenue Market Share (2013-2018)
Table Pfizer, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer, Inc. Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Production Growth Rate (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Production Market Share (2013-2018)
Figure Pfizer, Inc. Rare Disease Drug Revenue Market Share (2013-2018)
Table Sanofi S.A. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi S.A. Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Sanofi S.A. Rare Disease Drug Production Growth Rate (2013-2018)
Figure Sanofi S.A. Rare Disease Drug Production Market Share (2013-2018)
Figure Sanofi S.A. Rare Disease Drug Revenue Market Share (2013-2018)
Table Alexion Pharmaceuticals, Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alexion Pharmaceuticals, Inc. Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Production Growth Rate (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Production Market Share (2013-2018)
Figure Alexion Pharmaceuticals, Inc. Rare Disease Drug Revenue Market Share (2013-2018)
Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Eli Lilly and Company Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Eli Lilly and Company Rare Disease Drug Production Growth Rate (2013-2018)
Figure Eli Lilly and Company Rare Disease Drug Production Market Share (2013-2018)
Figure Eli Lilly and Company Rare Disease Drug Revenue Market Share (2013-2018)
Table Novo Nordisk A/S Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novo Nordisk A/S Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Production Growth Rate (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Production Market Share (2013-2018)
Figure Novo Nordisk A/S Rare Disease Drug Revenue Market Share (2013-2018)
Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AstraZeneca Rare Disease Drug Capacity, Production (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2013-2018)
Figure AstraZeneca Rare Disease Drug Production Growth Rate (2013-2018)
Figure AstraZeneca Rare Disease Drug Production Market Share (2013-2018)
Figure AstraZeneca Rare Disease Drug Revenue Market Share (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Rare Disease Drug
Figure Manufacturing Process Analysis of Rare Disease Drug
Figure Rare Disease Drug Industrial Chain Analysis
Table Raw Materials Sources of Rare Disease Drug Major Manufacturers in 2017
Table Major Buyers of Rare Disease Drug
Table Distributors/Traders List
Figure Global Rare Disease Drug Capacity, Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Global Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Rare Disease Drug Price (Million USD) and Trend Forecast (2018-2025)
Table Global Rare Disease Drug Production (K Doses) Forecast by Region (2018-2025)
Figure Global Rare Disease Drug Production Market Share Forecast by Region (2018-2025)
Table Global Rare Disease Drug Consumption (K Doses) Forecast by Region (2018-2025)
Figure Global Rare Disease Drug Consumption Market Share Forecast by Region (2018-2025)
Figure North America Rare Disease Drug Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure North America Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table North America Rare Disease Drug Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Asia-Pacific Rare Disease Drug Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Asia-Pacific Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Asia-Pacific Rare Disease Drug Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Europe Rare Disease Drug Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Europe Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Europe Rare Disease Drug Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Central & South America Rare Disease Drug Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Central & South America Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Central & South America Rare Disease Drug Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure Southeast Asia Rare Disease Drug Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Southeast Asia Rare Disease Drug Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Figure India Rare Disease Drug Production (K Doses) and Growth Rate Forecast (2018-2025)
Figure India Rare Disease Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table India Rare Disease Drug Production, Consumption, Export and Import (K Doses) Forecast (2018-2025)
Table Global Rare Disease Drug Production (K Doses) Forecast by Type (2018-2025)
Figure Global Rare Disease Drug Production (K Doses) Forecast by Type (2018-2025)
Table Global Rare Disease Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Rare Disease Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Rare Disease Drug Price Forecast by Type (2018-2025)
Table Global Rare Disease Drug Consumption (K Doses) Forecast by Application (2018-2025)
Figure Global Rare Disease Drug Consumption (K Doses) Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Source
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
